Followers | 17 |
Posts | 2756 |
Boards Moderated | 0 |
Alias Born | 02/20/2011 |
Wednesday, October 22, 2014 9:23:53 PM
True2Bid and Applied DNA Sciences Enter into Collaboration Agreement
Follow this company
Companies Mentioned
PK:TRTB
10/07/2014 [ACCESSWIRE]
Companies to Establish a Proof of Concept for a DNA-Based Solution for Authentication and Chain of Custody
BOCA RATON, FL / ACCESSWIRE / October 7, 2014 / True2Beauty, Inc., (OTC Pink: TRTB) (PINKSHEETS: TRTB), a company that operates an online retailing platform through its True2Bid, Inc. subsidiary, is pleased to announce the signing of a collaboration agreement with Applied DNA Sciences to establish a proof of concept for a unique authenticity and chain of custody solution.
Under the terms of the agreement True2Bid will purchase a SigNature(R) DNA mark and work in conjunction with Applied DNA Sciences to use that mark for applications for certain agreed upon market opportunities. The companies will work together exclusively during an eight month collaboration period to define a proof of concept and test the economic viability of that concept within those specific markets.
"As an online retailer with a fresh marketing concept, reputation and reliability is at the cornerstone of our business model. We are excited to work with Applied DNA and apply their DNA mark to specific target markets we intend to service through our online retail platform. We have committed financial and operational resources to develop this concept, which we believe can create an unparalleled chain of authenticity, adding immediate value for customers in the intended target markets covered by this agreement," stated William Bollander, CEO of True2Beauty.
"Applied DNA Sciences sees a number of promising market areas to explore the development of authenticity solutions using its proprietary SigNature(R) DNA mark to significantly enhance value," commented Jim Hayward, CEO of Applied DNA Sciences. "Our discussions with TRTB management have been focused on a business partnership model that can address specific needs in large potential market opportunities while providing ongoing revenue streams for both companies. We look forward to working with TRTB in the coming months to reach our common goal of establishing a long lasting and profitable business partnership."
The Company will provide further updates as the site prepares for a full, hard launch.
About True2Beauty, Inc.
True2Beauty is the parent company of BetUGetIt(TM), an online retail platform. The BetUGetIt(TM) site is focused on delivering users a wide array of products that can either be won in an action packed environment of a live auction or purchased outright at considerable discounts to MSRP. With a guarantee that "The Only Risk Is Having Fun," participants can now experience a new and exciting way to shop for the products they want, at great discounts.
Recent APDN News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM